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Abstract
Objectives To quantify global consumption of key dietary fats and oils
by country, age, and sex in 1990 and 2010.
Design Data were identified, obtained, and assessed among adults in
16 age- and sex-specific groups from dietary surveys worldwide on
saturated, omega 6, seafood omega 3, plant omega 3, and trans fats,
and dietary cholesterol. We included 266 surveys in adults (83%
nationally representative) comprising 1 630 069 unique individuals,
representing 113 of 187 countries and 82% of the global population. A
multilevel hierarchical Bayesian model accounted for differences in
national and regional levels of missing data, measurement
incomparability, study representativeness, and sampling and modelling
uncertainty.
Setting and population Global adult population, by age, sex, country,
and time.
Results In 2010, global saturated fat consumption was 9.4%E
(95%UI=9.2 to 9.5); country-specific intakes varied dramatically from
2.3 to 27.5%E; in 75 of 187 countries representing 61.8% of the world’s
adult population, the mean intake was <10%E. Country-specific omega
6 consumption ranged from 1.2 to 12.5%E (global mean=5.9%E);
corresponding range was 0.2 to 6.5%E (1.4%E) for trans fat; 97 to 440
mg/day (228 mg/day) for dietary cholesterol; 5 to 3,886 mg/day (163
mg/day) for seafood omega 3; and <100 to 5,542 mg/day (1,371 mg/day)
for plant omega 3. Countries representing 52.4% of the global population
had national mean intakes for omega 6 fat ≥5%E; corresponding
proportions meeting optimal intakes were 0.6% for trans fat (≤0.5%E);
87.6% for dietary cholesterol (<300 mg/day); 18.9% for seafood omega
3 fat (≥250 mg/day); and 43.9% for plant omega 3 fat (≥1,100 mg/day).
Trans fat intakes were generally higher at younger ages; and dietary
cholesterol and seafood omega 3 fats generally higher at older ages.
Intakes were similar by sex. Between 1990 and 2010, global saturated
fat, dietary cholesterol, and trans fat intakes remained stable, while
omega 6, seafood omega 3, and plant omega 3 fat intakes each
increased.
Conclusions These novel global data on dietary fats and oils identify
dramatic diversity across nations and inform policies and priorities for
improving global health.
Introduction
By 2020, nearly 75% of all deaths and 60% of all disability
adjusted life years worldwide will be attributable to
non-communicable chronic diseases including cardiovascular
diseases, type 2 diabetes, obesity, and cancers, with the largest
increases and burdens in low andmiddle income countries rather
than high income countries.1 2 Most of these burdens occur
prematurely and can be prevented or delayed, making the
identification and targeting of the modifiable risk factors with
greatest impact on these diseases among the greatest health
priorities of our time.
For decades healthcare systems, clinicians, and scientists have
focused on the medical, drug treatment model of disease that
highlights intermediate, downstream, metabolic risk factors as
established predictors of diseases rather than fundamental root
causes such as diet and lifestyle.3 The consequences of this
narrow approach are evident: the global obesity epidemic and
the pandemic of chronic diseases that has now swept the world.
As demonstrated by the Global Burden of Diseases Study’s
capstone papers,4 and as highlighted throughout the reports from
the United Nations high level meeting on non-communicable
disease prevention and control (http://www.who.int/nmh/events/
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Appendix 1. Sample of the standardised electronic data extraction sheet.
Appendix 2. The Bayesian hierarchical model for country-level and regional estimates.
eTables 1-7. Details of world regions and countries used in study, characteristics of data sources, and consumption levels of dietary fats and oils
analysed.
eFig 1. Global and regional mean consumption levels of dietary saturated fat (panel 1) and omega 6 polyunsaturated fat (panel 2) in 2010 for adult
men (A) and women (B)  20 years of age. See eTable 5 for numerical mean estimates and uncertainty intervals.
eFig 2. Global and regional mean consumption levels of dietary trans fat (panel 1) and cholesterol (panel 2) in 2010 for adult men (A) and women
(B) aged  20 years of age. See eTable 5 for numerical mean estimates and uncertainty intervals.
eFig 3. Global and regional mean consumption levels of dietary seafood omega 3 fat (panel 1) and plant omega 3 fat (panel 2) in 2010 for adult
men (A) and women (B)  20 years of age. See eTable 5 for numerical mean estimates and uncertainty intervals.
eFig 4. Global and national mean dietary saturated fat (A), omega 6 polyunsaturated fat (B), and trans fat (C) (panel 1), and dietary cholesterol (A),
seafood omega 3 fat (B), and plant omega 3 fat (C) (panel 2) consumption levels in 2010 for adult men and women  20 years of age in relation to
their uncertainty. See eTables 3 and 5 for numerical mean estimates and uncertainty intervals.
eFig 5. Global and regional mean dietary saturated fat (A), omega 6 polyunsaturated fat (B), and trans fat (C) (panel 1), and dietary cholesterol (A),
seafood omega 3 fat (B), and plant omega 3 fat (C) (panel 2) consumption levels in 1990 and 2010 for adult men and women  20 years of age in
relation to their uncertainty. See eTable 6 for numerical mean estimates and uncertainty intervals.
eFig 6. Global and regional mean dietary saturated fat (A), omega 6 polyunsaturated fat (B), and trans fat (C) (panel 1), and dietary cholesterol (A),
seafood omega 3 fat (B), and plant omega 3 fat (C) (panel 2) consumption levels for adults  20 years of age by age. Error bars for each region
represent a lower side of 95% uncertainty interval (UI) for the lowest mean value and an upper side of 95% UI for the highest mean value.
eFig 7 Panel 1(A). Regional model fits for saturated fat intake. Model fits in relation to original data by region and dietary risk factor in 2010. The
units on the y axis are units (% energy or mg)/day of the diet risk factor, divided by 10 000 to ensure that all exposures fit between Dismod’s expected
range of [0,1]. The x axis is age of the observation, and each green bar represents a single data point. The horizontal bar of each observation
indicates the age range, and the vertical bar represents the uncertainty around the point estimate, based either on the effective sample size, the
standard error or the direct 95 % confidence interval in the input data. These raw data points are adjusted for study level covariates, should they
be present in the model (this is indicated by red “Adjusted Data” at the bottom right of the graph). The dotted green curve with narrow vertical
uncertainty lines is the prior, based on a negative binomial regression of all the data in the model (global level) with both study level and country
level covariates. The solid green curve with shaded uncertainty is the population-weighted posterior which is informed by the prior and the
country-specific raw data.To the right of the model fit graph are three smaller visualizations for the fixed effects (fe), random effects (re) and median
adjusted relative error (MARE). The coefficients for both the random and fixed effects are in natural logarithm space on their respective x axes. The
random effects also indicate the country source of the raw data. The country-level random effects sum to zero within a region; regional random
effects sum to zero within a super-region and so on. The random and fixed effects are global and vary only by parameter type. The MARE plot gives
an indication of the residuals which aren’t accounted for by the random or fixed effects; a larger MARE indicates a poorly specified model. Each
raw data point is visualized by a separate blue square in this plot.
eFig 7 Panel 1(B). Regional model fits for omega 6 polyunsaturated fat intake. See legend for Panel 1(A) for explanation.
eFig 7 Panel 1(C). Regional model fits for trans fat intake. See legend for Panel 1(A) for explanation.
eFig 7 Panel 2(A). Regional model fits for dietary cholesterol intake. See legend for Panel 1(A) for explanation.
eFig 7 Panel 2(B). Regional model fits for seafood omega 3 fat intake. See legend for Panel 1(A) for explanation.
eFig 7 Panel 2(C). Regional model fits for plant omega 3 fat intake. See legend for Panel 1(A) for explanation.
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un_ncd_summit2011/en/), diet is one of the fundamental risk
factors for health, disease, and disability in the world. Indeed,
given that trends in metabolic risk factors such as blood pressure,
cholesterol, glucose, and body mass index are being largely
driven by nutrition, suboptimal diet is the single leading
modifiable cause of poor health in the world, exceeding the
burdens due to tobacco and excess alcohol consumption
combined.4 Eight of the top 20 individual causes of disease
burden worldwide are due to poor nutrition, largely because of
increased risk of chronic diseases.4
Over the past several decades, multiple diet-disease
relationships, establishing either beneficial or harmful effects
of specific dietary fats,5-12 have been identified and been the
target of major policy programmes. And yet, the global patterns
and distributions of consumption of key dietary fats and oils,
as well as heterogeneity in these patterns by region, country,
age, and sex, are not well established. Prior global assessments
based on dietary habits at the individual level did not evaluate
dietary fats and oils,13 and few countries have published
nationally representative data on their consumption. Most
estimates of global dietary fats and oils have relied largely on
crude disappearance or expenditure data,14-18 which imperfectly
capture consumption levels, cannot evaluate differences within
the population, and often exclude key fats such as trans fats or
plant omega 3 fats. Prior estimates have also not explicitly
addressed missing data for certain age groups or regions,
distinguished nationally representative surveys from regional
or community based surveys, quantified uncertainty in the
dietary estimates, or evaluated heterogeneity by age and sex. In
particular, age- and sex-specific national consumption levels
are essential for quantifying the impact on burdens of disease
risk, which are not uniformly distributed across the population.
These limitations have together precluded valid quantitative
assessment of the impact of specific dietary fats and oils on
chronic diseases worldwide, of the epidemiologic nutrition
transitions occurring in low and middle income nations, and of
the most relevant dietary priorities in different nations. To
address these issues, we identified specific dietary fats and oils
with evidence for largest public health impact; characterised
optimal consumption levels; and systematically investigated
global dietary habits, based largely on individual-level,
nationally representative surveys, and derived using comparable
and consistent methods to construct a global dietary database
having quantitative estimates of consumption of key dietary
fats and oils, by region, country, time, age, and sex.
Methods
Study design
This work was performed by the Nutrition and Chronic Diseases
Expert Group (NutriCoDE) as part of the 2010 Global Burden
of Diseases, Injuries, and Risk Factors (GBD) Study.4 Our
methods for identification, access, and selection of dietary risk
factors and data have been reported.19 Because we used
de-identified national datasets, this research was reviewed by
the Harvard School of Public Health institutional human subjects
committee and deemed to be exempt from human subjects
research requirements. To generate valid, comparable estimates
of consumption of fats and oils around the world, we used
consistent methods across regions, countries, age and sex
subgroups, and time to:
• Identify specific dietary fats and oils with evidence for
largest public health impact, based on strength of evidence
for aetiological effects on coronary heart disease, stroke,
type 2 diabetes, or cancers
• Systematically search for nationally representative data
sources from around the world on individual level dietary
consumption of these fats and oils, including by age and
sex
• Retrieve data, including assessment of quality and
representativeness, maximisation of measurement
comparability and consistency, and ascertainment of
missing data and uncertainty
• Estimate consumption levels by region, country, age, sex,
and time, accounting for missing data, incomparability of
measured values, and sampling and modelling uncertainty
• Characterise optimal consumption levels of each dietary
fat and oil, based on observed intakes associated with
lowest disease risk and observed mean national
consumption levels globally, to place the observed intakes
in context and enable quantification of relevant attributable
disease burdens.
Identification of dietary fats and oils with
largest public health impact
We reviewed the evidence for aetiological effects on chronic
diseases including coronary heart disease, stroke, type 2
diabetes, and cancers, based on multiple criteria for assessing
causality of diet-disease relationships.20-22 We required
convincing or probable evidence for effects on clinical events
(such as myocardial infarction) rather than simply on
physiological risk factors (such as blood cholesterol
concentration). The detailed results for our assessments of
aetiological effects of dietary fats and oils have been
reported.19 23 We identified aetiological effects of omega 6
polyunsaturated fat as a replacement for saturated fat, seafood
omega 3 fats, and trans fats on coronary heart disease.6-12 We
did not identify convincing or probable evidence for aetiological
effects of these fats on stroke, diabetes, or cancers; or of total
fat, monounsaturated fat, plant omega 3 fats, or dietary
cholesterol (evaluated mainly through egg consumption) on
coronary heart disease, stroke, type 2 diabetes, or cancers.8-31
Systematic searches for national dietary data
We performed systematic searches for individual level dietary
surveys in all countries. Surveys with evidence for selection
bias or measurement bias were excluded. Using standardised
criteria and methods,19 we searched multiple online databases
from March 2008 to September 2010 without date or language
restrictions. From these searches, we identified comparably few
appropriate published data sources. Thus, from March 2008 to
July 2012, we also used extensive personal communications
with researchers and government authorities throughout the
world, including authors of published nutrition studies and
nutrition authorities in a given country, inviting them to be
corresponding members of the NutriCoDE group (fig 1⇓). For
countries lacking identified national or subnational
individual-level surveys by thesemethods, we searched for other
potential data sources, including individual level surveys from
large cohorts, the WHO Global Infobase, the WHO Stepwise
Approach To Surveillance (STEPS) database, and budget survey
data at the household level. Given our aim to evaluate chronic
diseases, we focused on data from adults (aged ≥20 years). The
results of our search strategy by dietary factor, time, and region
have been reported.32 A total of 266 surveys in adults
representing 113 of 187 countries and 82% of the global
population were identified (fig 1⇓).
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Data retrieval and standardisation
Data retrieval followed the 2010 Global Burden of Diseases
study’s comparative risk assessment framework,33 collecting
quantitative data on consumption in 16 age- and sex-specific
subgroups across 21 world regions (see eTable 1 of data
supplement) and two time periods (1990 and 2010). Most
published or publically available dietary data were limited or
not in the relevant format. For 173 surveys, 99 corresponding
members provided original raw data to us or re-analysed their
raw data according to our specifications, providing age and sex
stratified dietary results in specified metrics and units using a
standardised electronic format (appendix 1 of data supplement).
Optimal and alternative metrics and units were defined for each
dietary factor,19 with optimal units matching those of studies
used to evaluate relationships with disease risk as well as major
dietary guidelines. Based on these criteria, dietary factors were
evaluated as percentage energy (saturated fat, omega 6
polyunsaturated fat, trans fat) or as mg/day standardised using
the residual method34 to 2000 kcal/day (dietary cholesterol,
seafood omega 3 fat, plant omega 3 fat). The surveys providing
data on dietary fats and oils are listed in eTable 2 of data
supplement.
For each survey, we extracted data on survey characteristics,
dietary metrics, units, and mean and distribution (such as
standard deviation) of consumption of each dietary fat and oil,
by age and sex (eTable 2). Data were double checked for
extraction errors and assessed for plausibility. We assessed
survey quality by evaluating evidence for selection bias, sample
representativeness, response rate, and validity of diet assessment
method.19 Measurement comparability across surveys was
maximised by using a standardised data analysis approach that
(1) accounted for sampling strategies within the survey by
including sampling weights (if available), (2) used the average
of all days of dietary assessment to quantify mean intakes, (3)
used a corrected population standard deviation to account for
within person variation versus between person variation, (4)
used standardised dietary metrics and units of measure across
surveys, and (5) adjusted for total energy to reducemeasurement
error and account for differences in body size, metabolic
efficiency, and physical activity.34
Quantification of global, regional, and national
distributions
Our systematic approaches to survey identification and data
retrieval identified gaps in data for certain countries, certain
dietary fats or oils across countries, or time periods.
Furthermore, even using the systematic data retrieval and
standardisation methods described above, identified surveys
and measures were not always comparable—for example,
varying in representativeness, urban or rural coverage, age
groups, dietary instruments, or dietary metrics. To address
missing data, incomparability, and related effects on uncertainty
of dietary estimates, we developed an age integrating Bayesian
hierarchical imputation model (appendix 2 of data supplement).4
This model estimated the mean consumption level and its
statistical uncertainty for each age, sex, country, and year
stratum. For each dietary factor, primary inputs were the
survey-level quantitative data, including country-, time-, age-,
and sex-specific consumption levels (mean, distribution); data
on the numbers of subjects in each strata; survey level indicator
covariates for sampling representativeness, dietary assessment
method, and type of dietary metric; and country, region (21
Global Burden of Diseases regions), and super-region (7 Global
Burden of Diseases groupings of regions) random effects.
Additional country-level, time-varying (year-specific) covariates,
which were available in all years including 2010, included
lagged distributed income35 and food disappearance data derived
and standardised from United Nations Food and Agricultural
Organization food disappearance balance sheets,16 including 17
nutrients or food groups and four factors derived from principal
components analysis of these 17 variables. The final model
covariates for each dietary risk factor are presented in table 1⇓.
The final national, regional, and global estimates were calculated
as population-weighted averages of the corresponding age- and
sex-specific strata. Using these methods, we quantified the
consumption levels of saturated fat, omega 6 polyunsaturated
fat, trans fat, dietary cholesterol, seafood omega 3 fat, and plant
omega 3 fat, and among men and women in 187 countries in
1990 and 2010.
The model included additional offset and variance components
to account for differences between primary and secondary
dietary metrics, national and subnational surveys, and individual
and household dietary data—in each case allowing greater
influence of the former.Model validity across different iterations
was evaluated using cross validation, randomly omitting 10%
of the raw data and comparing the imputed intakes with the
original raw data. Sources of uncertainty were identified and
incorporated, including from missing country data, sampling
uncertainty of original data sources, and additional uncertainty
associated with suboptimal metrics, subnational samples, or
household level surveys. Using simulation (Monte Carlo)
analyses, we drew 1000 times from the posterior distribution
of each exposure for each age, sex, country, and year stratum;
computed the mean exposure from the 1000 draws; and the 95%
uncertainty intervals as the 2.5th and 97.5th centiles of the 1000
draws. Absolute and relative differences in exposure between
1990 and 2010 were calculated at the draw level to account for
the full spectrum of uncertainty.We used Spearman correlations
to evaluate interrelations between specific dietary fats and oils.
Characterisation of optimal consumption
To place observed consumption levels in context and allow
separate assessment of impact on disease, for each dietary factor
we characterised the optimal, yet feasible, consumption levels
(table 2⇓).19 37 This was based on both the mean observed
consumption associated with lower disease risk inmeta-analyses
of clinical endpoints and the mean national consumption levels
observed in at least two or three countries around the world. As
another criterion, we also considered whether such characterised
optimal consumption levels were broadly consistent with current
major dietary guidelines.
Results
Global consumption in 2010
In 2010, mean global saturated fat intake in adults was 9.4% of
energy intake (%E) (95% uncertainty interval 9.2%E to 9.5%E),
with marked variation across regions and countries (table 3⇓,
fig 2⇓). A 5.5-fold variation was identified across the 21 Global
Burden of Diseases Study regions (from 4.3%E to 23.5%E),
and a 12-fold variation across the 187 countries (from 2.3 to
27.5%E). Highest intakes were identified in Samoa, Kiribati,
and similar palm oil producing island nations; as well as Sri
Lanka, Romania, and Malaysia (eTable 3 of data supplement).
Lowest intakes were in Bangladesh, Nepal, Bolivia, Bhutan,
and Pakistan. In 75 of 187 countries, representing 2.73 billion
adults and 61.8% of the global adult population, mean
consumption was <10%E.
Worldwide omega 6 polyunsaturated fat mean intake was 5.9%E
(table 3⇓, fig 2⇓), with approximately 3-fold variation between
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2014;348:g2272 doi: 10.1136/bmj.g2272 (Published 15 April 2014) Page 4 of 20
RESEARCH
highest (8.5%E) and lowest (2.5%E) regions. Country-specific
intake ranged from 1.2%E to 12.5%E. Highest intake was in
Bulgaria, followed by other Central European nations, Lebanon,
Kazakhstan, and Belarus. Lowest intake was seen in Kiribati,
Samoa, and Vanuatu (eTable 3). Only one of 187 countries
(Bulgaria) had intakes at or above the optimal level of 12%E.
Only 94 of 187 countries had intakes at or above 5%E,
representing 2.3 billion adult people and 52.4% of the world
adult population. Notably, intakes of saturated fat and omega
6 fat were only modestly intercorrelated: regional r
(Spearman)=−0.16, national r=−0.22.
Mean global trans fat intake was 1.40%E, but with a 5-fold
difference (from 0.6 to 2.9%E) across regions (table 3⇓, fig 3⇓)
and a 28-fold difference (from 0.2 to 6.5%E) across countries
(eTable 3). Egypt had the highest consumption, followed by
Pakistan, Canada, Mexico, and Bahrain. Several island nations
in the Caribbean including Barbados and Haiti had the lowest
consumption, followed by East Sub-Saharan African nations
such as Ethiopia and Eritrea. Only 12 of 187 countries had mean
consumption ≤0.5%E. The remaining countries (99.4% of the
global adult population) had higher intakes, including 12
countries with mean consumption >2.0%E. Regional and
national correlations between saturated fat and trans fat were
−0.25 and 0.06, respectively.
Globally, mean dietary cholesterol intake was 228mg/day (table
3⇓, fig 3⇓). Across the Global Burden of Diseases Study regions,
roughly 2.4-fold differences were identified, and across countries
4.5-fold differences (from 97 to 440 mg/day). Romania, and
other Eastern European nations, such as Latvia and Belarus, as
well as Algeria, Paraguay, Japan, and Hungary had highest
consumption (eTable 3 of data supplement). Lowest intakes
were in Bangladesh, Nepal, other South Asian nations, and East
Sub-Saharan African nations such as Rwanda and Burundi.
Overall, 155 of 187 countries hadmean cholesterol consumption
<300 mg/day, in line with current recommendations,7
representing 3.9 billion adults and 87.6 % of the world adult
population. Both regionally and nationally, dietary cholesterol
did not strongly correlate with saturated fat consumption (r=0.13
and 0.09, respectively).
Global mean intake of seafood omega 3 fats was 163 mg/day,
with tremendous regional variation (from <50 to >700 mg/day)
and national variation (from 5 to 3886 mg/day) (table 3⇓, fig
4⇓). Highest intakes were identified in island nations including
Maldives, Barbados, the Seychelles, and Iceland; as well as in
Malaysia, Thailand, Denmark, South Korea, and Japan (eTable
3). Lowest intakes were in Zimbabwe, Lebanon, the Occupied
Palestinian Territory, Botswana, and Guinea-Bissau. In 45 of
187 countries mean intakes were ≥250 mg/day, in line with
current guidelines.7 Notably, 100 nations had very low mean
consumption (<100mg/day), generally in Sub-Saharan African
and Asian regions as well as North Africa/Middle East,
representing three billion adults and 66.8% of the world adult
population.
Mean plant omega 3 consumption was 1371 mg/day, with a
10-fold range (302 to 3205 mg/day) across regions (table 3⇓,
fig 4⇓). By country, intake ranged from <100 to >3000 mg/day
(eTable 3). Highest consumption was seen in Jamaica, China,
the UK, Tunisia, Angola, Senegal, Algeria, Canada, and the
US. Several of these nations have substantial linseed production,
such as Canada (which also has high canola production), China,
and the US. Several South American nations (Brazil, Uruguay,
Paraguay, Argentina) also had higher plant omega 3
consumption, potentially due to availability of chia seeds high
in α-linolenic acid, or intakes of other nuts and seeds. Lowest
intakes were found in Israel, the Solomon Islands, Sri Lanka,
Comoros, Saint Lucia, and the Philippines. Although we did
not identify sufficient evidence to set a specific optimal intake
level for preventing chronic diseases,World Health Organization
guidelines suggest mean population plant omega 3 consumption
of ≥0.5%E, or ≥1100 mg for a 2000 kcal/day diet.6 Based on
this, 52 of 187 countries met this intake. Among the 135
countries with lower consumption, 61 had intakes <500mg/day,
substantially below current recommendations, representing 800
million adults and 17.8% of the global adult population.
Differences in consumption by sex and age
Within regions and countries, consumption levels of fats and
oils were generally similar by sex (eFigs 1-5, eTables 5-7 of
data supplement). For example, compared with men, women
generally consumed only slightly more saturated fat (roughly
0.3%E) and plant omega 3 (roughly 16 mg/day). Intakes of
saturated fat, omega 6 polyunsaturated fat, and plant omega 3
were also relatively similar by age (eFig 6). Conversely, trans
fat consumption varied more greatly by age with generally
higher intakes in younger adults, particularly in South Asia,
High-Income North America, and Central and Tropical Latin
America. Dietary cholesterol also varied by age, but with higher
intakes at older rather than at younger ages, especially in
High-Income Asia Pacific, Central Asia, Oceania, and the
Caribbean. Seafood omega 3 consumption was also generally
higher among older compared with younger adults, most
apparent in High-Income Asia Pacific, Southeast Asia,
Australasia, Oceania, and Western Europe.
Changes in consumption between 1990 and
2010
Globally, mean saturated fat intake was stable between 1990
and 2010 (change: +0.1%E (95% uncertainty interval −0.1 to
0.3)) (fig 5⇓). Intake nominally increased in 13 regions, although
these increases only achieved statistical significance in Southern
Sub-Saharan Africa (+0.9%E (0.5 to 1.4)), Tropical Latin
America (+0.6%E (0.3 to 0.9)), Central Latin America (+0.5%E
(0.1 to 1.0)), and South Asia (0.4%E (0.2 to 0.6)). Intake
nominally decreased in eight regions, although none of these
decreases was statistically significant, including in Eastern
Europe (−1.9%E (−4.6 to 0.8)) and Central Asia (−0.7%E (−2.2
to 0.8)). Among countries, the greatest absolute increases
occurred in Zambia (+4.6%E (2.3 to 7.1)), Timor-Leste (+4.4%E
(0.6 to 8.5)), Georgia (+4.0%E (1.2 to 6.7)), Bosnia and
Herzegovina (+4.0%E (0.9 to 7.3)), and Mauritania (+3.8%E
(0.9 to 6.9)) (eTable 4 of data supplement). During this same
period, Lithuania experienced the largest declines in saturated
fat (−4.4%E (−5.6 to −3.1)), followed by Tajikistan (−4.1%E
(−7.5 to −1.1)), Algeria (−3.8%E (−5.0 to −2.7)), Estonia
(−2.8%E (−4.0 to −1.7)), and Bulgaria (−2.7%E (−4.4 to −1.1)).
By country, mean intake declined by at least 2%E in only five
countries and by at least 1%E in 10 countries, while it increased
by at least 2%E in nine countries and by at least 1%E in 10
countries (eTable 4).
Mean omega 6 polyunsaturated fat intake increased by 0.5%E
(0.3 to 0.8) globally (fig 5⇓), including statistically significant
increases in nine regions and non-significant trends in nine
more. Largest increases were in Eastern Europe (+1.6%E (0.3
to 3.1)), Central Asia (+1.3%E (0.6 to 2.1)), and East Asia
(+1.1%E (0.6 to 1.6)). Consumption levels remained stable in
Western Europe and East Sub-Saharan Africa, and nominally
decreased in Australasia, Andean Latin America, and Oceania,
with a significant decrease only in the latter (−0.6 %E (−1.2 to
0.0)). Among individual nations, largest increases occurred in
Eastern Europe including Latvia (+3.4%E (1.9 to 5.2)) and
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Belarus (+2.7%E (0.8 to 4.7)), and in Kazakhstan (+3.2%E (1.2
to 5.5)), El Salvador (+2.6%E (1.3 to 3.9)), Georgia (+2.5%E
(0.9 to 4.1)) and Costa Rica (+2.3%E (0.9 to 3.7)) (eTable 4).
Greatest decreases were in Malta (−1.4%E (−2.8 to −0.1)),
Mauritania (−1.3%E (−2.7 to 0.0)), Mali (−1.3%E (−2.7 to
0.0)), and Denmark (−1.3%E (−2.3 to −0.3)).
Globally, mean trans fat intake remained relatively stable
between 1990 and 2010 (+0.1%E (0.1 to 0.2)) (fig 5⇓).
Consumption increased in six regions, largest in North
Africa/Middle East (+0.4%E (0.1 to 0.7)) and South Asia
(+0.3%E (0.2 to 0.5)). Intakes nominally decreased in Southern
Sub-Saharan Africa (−0.1%E (−0.3 to 0.2)) andWestern Europe
(−0.1%E (−0.2 to 0.0)). By nation, mean trans fat intakes were
also relatively unchanged between 1990 and 2010, but with
broader uncertainty due to more limited data across time (eTable
4). Largest increases occurred in South Asian and North
African/Middle Eastern nations, including Pakistan (+1.5%E
(0.9 to 2.2)), Iran (+0.6%E (0.2 to 1.0)), as well as in Costa Rica
(+0.3%E (0.1 to 0.5)). Several Western European nations had
larger decreases, including Norway (−0.3%E (−0.5 to −0.1))
and the Netherlands (−0.3%E (−0.5 to 0.0)).
Mean dietary cholesterol consumption was stable worldwide
(global change +7 mg/day (−1 to 15)). Intake increased in East
Asia (+20 mg/day (9 to 31)) and Tropical Latin America (+19
mg/day (9 to 30)), and decreased in Australasia (−18 mg/day
(−34 to −2)). By nation, greatest increases were in Samoa (+58
mg/day (30 to 86)), Taiwan (+29 mg/day (12 to 45)), Barbados
(+24 mg/day (2 to 48)), and Indonesia (+21 mg/day (1 to 44))
(eTable 4). Largest decreases were in Lebanon (−33 mg/day
(−55 to −11)), Estonia (−33mg/day (−60 to −8)), New Zealand
(−26 mg/day (−45 to −5)), and Finland (−25 mg/day (−40 to
−9)).
Worldwide seafood omega 3 consumption increased by 24
mg/day (12 to 37) (fig 5⇓), including largest increases in
Southeast Asia (+146 mg/day (22 to 267)), Australasia (+88
mg/day (47 to 130)), Eastern Europe (+53 mg/day (21 to 87)),
and Western Europe (+53 mg/day (2 to 103)). No regions had
certain decreases; non-significant decreases were seen in Andean
Latin America (−65 mg/day (−160 to 20)), and Central
Sub-Saharan Africa (−27mg/day (−66 to 10)). Of 104 countries
with consumption <100 mg/day in 1990, 93 remained <100
mg/day in 2010. Nationally, greatest absolute increases were in
South Korea (+240 mg/day (133 to 345)), Indonesia (+187
mg/day (102 to 281)), Croatia (+110 mg/day (63 to 167)),
Lithuania (+108mg/day (67 to 150)), andMoldova (+80mg/day
(32 to 145)) (eTable 4). The largest national decreases were in
North Korea (−81mg/day (−153 to −31)), Estonia (−50mg/day
(−95 to −10)), Guinea-Bissau (−26 mg/day (−52 to −8)), and
Taiwan (−25 mg/day (−35 to −16)).
Global plant omega 3 intake increased substantially, by 393
mg/day (299 to 500) (fig 5⇓). Intakes increased in all regions
except Oceania, which experienced a non-significant decline
(−51 mg/day (−347 to 221)). Largest increases were evident in
East Asia (+950 mg/day (725 to 1,173)), Eastern Europe (+570
mg/day (111 to 1,167)), Tropical Latin America (+534 mg/day
(415 to 652)), High-Income North America (+467 mg/day (382
to 553)), and Central Europe (+400mg/day (142 to 677)). Across
countries, greatest increases were in Latvia (+1427mg/day (531
to 2968)), Jamaica (+1205 mg/day (699 to 1731)), Lithuania
(+1002 mg/day (350 to 2069)), China (+978 mg/day (748 to
1202)), Estonia (+840 mg/day (151 to 1899)), Canada (+809
mg/day (622 to 999)), and the UK (+723 mg/day (515 to 931)).
The only statistically significant decrease was in Sweden (−238
mg/day (−395 to −97)).
Discussion
Relevance of findings for public health
This systematic investigation of individual-level dietary
assessments across the world provides, for the first time,
quantitative estimates of the global consumption ofmajor dietary
fats and oils by region, country, age, and sex, as well as the
uncertainty in these measurements. Since suboptimal diet is the
single leading cause of death and disability in the world today,4
these findings are highly relevant and of crucial interest to the
global scientific community, health professionals, policymakers,
and the public. The results demonstrate both similarities and
substantial diversity in consumption of fats and oils across
regions and nations. These findings facilitate quantitative
assessment of disease burdens attributable to these dietary
factors—such as by using state-transition Markov models,40 41
food impact models,42-44 and comparative risk
assessment4-45—and inform public health and policy priorities
for global, regional, and country-specific interventions.We also
assessed dietary changes over the past 20 years, although some
change estimates should be interpreted with caution due to more
limited available data over time.
Principal findings and interpretation
At a global level, mean consumption of saturated fat (9.4%E;
guideline<10%E) and dietary cholesterol (228 mg/day;
guideline<300 mg/day) were in line with current
recommendations or optimal intakes. Reductions of saturated
fat and dietary cholesterol have been longstanding public health
priorities. In 2010, national saturated fat and cholesterol intakes
met recommended intakes in countries representing about 60%
and 88% of the global adult population, respectively, suggesting
that this public health focus has been relatively successful.
Lowest intakes were identified in South and East Asia, South
America, and certain Caribbean nations. Such low intakes would
be beneficial for coronary heart disease, especially when
accompanied by reciprocal increases in polyunsaturated fat
intake,11 12 although very low saturated fat intake may increase
risk of other outcomes, such as hemorrhagic stroke.46 Based on
crude national availability and production estimates, saturated
fat consumption in some countries decreased after the mid-20th
century.47 Our results demonstrate relatively stable global and
regional intakes of saturated fat and cholesterol in more recent
years since 1990, except for further declines in certain Eastern
European nations. These relatively stable intakes since 1990
may be attributable in part to national programmes in some
countries having most of their effect on saturated fat and dietary
cholesterol before 1990. For example, Finland constitutes one
of the best documented examples of a community intervention
that had most of its effect prior to 1990, with further (though
smaller) declines seen after that.48 In addition, effectiveness of
recent population-level approaches to reduce saturated fat in
some countries could have been offset by increasing
Westernisation of diets and cultural and social prioritisation of
red meats.
Intakes of polyunsaturated fats, which have historically received
less public health and policy attention than saturated fat or
dietary cholesterol, were far below optimal worldwide. Intakes
were lowest in several Pacific island nations with very high
intakes of palm oil, creating adverse ratios of polyunsaturated
to saturated fats in these nations. Low intakes were also
identified in many Southeast Asian and Sub-Saharan African
countries, suggesting infrequent use of healthful vegetable oils
for cooking or preparing foods. In some regions such as Eastern
Europe, significant increases in polyunsaturated fat and
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reciprocal declines in saturated fat intake were identified
between 1990 and 2010, demonstrating feasibility of such broad
population substitutions to reduce coronary heart disease risk.
Ecological analyses based on commodity disappearance data
are consistent with these findings.49 Yet, despite promising
overall increases in polyunsaturated fat intakes over the past
two decades, the great majority of nations consume lower than
optimal levels, highlighting the need to increase public health
awareness and focus on healthy vegetable oils. The absence of
strong intercorrelation between polyunsaturated and saturated
fat consumption (nationally, −0.22) suggests that these dietary
risk factors for coronary heart disease are consumed relatively
independently and should be targeted separately to reduce risk,
particularly as benefits of replacing either saturated fat or
carbohydrates with polyunsaturated fat may be relatively
similar.11
Consistent with local cultures, highest seafood omega 3
consumption was identified in Pacific island nations, the
Mediterranean basin, Iceland, South Korea, and Japan (although
in the last two countries, large amounts are from salted foods,
which might increase stroke and gastric cancer).21-51 Yet, 142
countries representing nearly 80% of the world’s adult
population had mean seafood omega 3 intakes below 250
mg/day. Extremely low levels (often <100 mg/day) were
identified in Sub-Saharan Africa, South America (except Chile),
and Asian mainland nations. These findings highlight the dearth
of seafood omega 3 fats in much of the world and the need for
concerted public health and policy initiatives, including focus
on sustainable aquaculture and fishing practices, to increase
both supply and consumption. Whereas global seafood omega
3 consumption increased by about 25 mg/day between 1990
and 2010, we found that much of this was due to further
increases in countries already having relatively high
consumption.
In 2010, mean global consumption of plant omega 3 was 1371
mg/day. While this is consistent with current broad guidance
for adequate intakes (≥1100mg/day) and for preventing clinical
deficiency, optimal intakes of plant omega 3 for reducing
chronic diseases are not well established.6 28 In addition, we
identified remarkable heterogeneity in intakes, with roughly
10-fold differences across regions and 61 countries havingmean
intakes <500mg/day. Based on ecological evidence,52 increasing
plant omega 3 consumption can reduce population coronary
heart disease risk within a few years. However, definitive
cardiometabolic benefits and optimal intake levels are not yet
conclusively established.28 53 The extent to which the identified
regional and national increases in consumption since 1990 relate
to contemporaneous trends in mortality from cardiovascular
disease or other diseases requires further investigation.
While several high income countries have recently established
national or subnational policy efforts to reduce trans fat
consumption,54 55 little prior data was available on global intakes
of trans fat. Our findings suggest substantial heterogeneity across
the world. Relatively few countries had mean intakes >2%E;
conversely, most countries have not achieved optimal intakes
of <0.5%E. Highest consumption was evident in North America,
North Africa/Middle East, and South Asia, especially Pakistan.
While commercial foods are a major source of trans fat in high
income countries, intakes in low and middle income counties
are principally derived from home and street vendor use of
inexpensive partially hydrogenated cooking fats.56 57 In addition,
trans fat intake can be highly skewed in certain subgroups, so
that national means obscure population subsets withmuch higher
intakes. For example, whereas mean trans fat intake in India
was 1.1%E, consistent with proprietary industry data (personal
communication, Mark Stavro, Bunge LLC), both the industry
data as well as observations of Indian authorities suggest
substantial heterogeneity in trans fat intakes across different
Indian states, with several having much higher intakes.58 59 Our
findings also highlight the relatively limited data availability
on trans fat consumption in most nations compared with other
major dietary factors. These results demonstrate the need for
increased global and nation surveillance as well as consumption
reduction strategies.
Interestingly, intakes of most dietary fats and oils were similar
by sex, both regionally and within countries. Differences by age
were evident for trans fat, with highest consumption at younger
ages, perhaps because of greater consumption of processed
foods. Age differences were also seen for dietary cholesterol
and seafood omega 3 fats, with higher intakes at older ages. For
seafood omega 3 fats, the identified age pattern could relate to
a birth cohort effect—that is, maintenance of traditional diets
or to adoption of healthier diets at older ages because of
concerns about disease risk with aging. For cholesterol, the
identified age pattern highlights the need for further
investigation.
Strengths and limitations of study
Our investigation has several strengths. Systematic searches
and extensive direct contacts allowed us to identify, assess, and
compile, for the first time, global individual-level dietary data,
largely from national studies, on major dietary fats and oils
worldwide, including by age, sex, and time. Identified surveys
were evaluated for eligibility, measurement comparability, and
representativeness; and consistency across surveys was
maximised by standardised data extraction and analyses,
reinforcing validity and generalisability. Metrics and
measurement units were standardised across surveys and were
based on the evidence for effects on disease risk. Intakes were
adjusted for total energy, reducing measurement error; and
sensitivity analyses without energy adjustment were similar.
We developed a hierarchical imputation model to address
missing data, differences in representativeness and
comparability, and related effects on statistical uncertainty. We
collected data and imputed intakes using multiple surveys and
covariates over time, providing inference on dietary trends.
Potential limitations should be considered. Despite
comprehensive approaches to data identification and retrieval,
primary data were limited for certain dietary factors, countries,
and time periods: for example, more data were available for
2010 than 1990, and relatively little data were available in most
Sub-Saharan African nations or for trans fats and plant omega
3 fats. Yet, our modelling methods included surveys over time
within and across regions and countries, incorporated serial food
balance data as covariates, and quantified resulting statistical
uncertainty.
Our findings highlight the need for expanded systematic
surveillance of key dietary habits globally and especially in
regions with sparse data, including consideration of instrument
representativeness, validity, and comparability. Our results also
underscore the need for improved food composition databases
in many countries, especially for trans fat and plant omega 3
fats. To maximise practicality and data retrieval from diverse
global contacts, we focused on dietary fats and oils with
probable or convincing evidence of aetiological effects on
chronic diseases (for example, we did not gather data on
monounsaturated fats, which have differing relations with risk
when derived from animal versus plant sources60). Our methods
incorporated data across multiple years to derive the best
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estimates of intakes in 1990 and 2010, which increased validity
of estimates in these years but reduced the ability to detect acute
changes in national intakes, such as after major policy initiatives.
Because of our focus on chronic diseases, we did not collect
data in children. We plan to update and expand this work in the
future, to identify and incorporate new data, add new dietary
factors and age groups, and refine our estimation methods,
including for trends over time.
Conclusions and policy implications
Numerous epidemiological studies and several clinical trials
have documented the health benefits and harms of specific
dietary fats and oils. Yet, far less progress has been achieved
in understanding the patterns of global consumption as well as
heterogeneity by country, age, sex, and time. Our investigation,
founded on individual-level, nationally representative surveys,
provides a systematic and comprehensive quantitative
assessment of the global consumption of key dietary fats and
oils. These findings permit detailed investigation of the impact
of dietary habits on disease burdens across countries, of the
correlates and drivers of current dietary intakes and nutrition
transitions over time, and of the impact of national policies and
interventions that—intentionally or inadvertently—alter
population dietary intakes. These results inform national and
global efforts to alter diet, reduce disease, and improve
population health. Our findings also highlight specific data gaps
and provide a framework for future dietary surveillance using
validated, standardised, nationally representative surveys
supported by appropriate food composition data. Understanding
the global patterns and impact of suboptimal dietary habits is
essential to inform, implement, and evaluate specific
interventions and policies to reduce disease burdens and
disparities around the world.
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What is already known on this topic
Suboptimal diet is the single leading modifiable cause of poor health in the world
Multiple diet-disease relationships, establishing either beneficial or harmful effects of specific dietary fats, have been identified
Most estimates of global dietary fats and oils have relied largely on crude disappearance or expenditure data, and few countries have
published nationally representative data on consumption of major dietary fats and oils
What this study adds
This systematic investigation of individual-level dietary assessments across the world provides quantitative estimates of the global
consumption of major dietary fats and oils by region, country, age, and sex, as well as the uncertainty in these measurements
The results demonstrate both similarities (such as between men and women) and substantial diversity (such as seafood and plant omega
3 fats) in consumption of fats and oils across regions and nations
The findings facilitate quantitative assessment of disease burdens attributable to these dietary factors and can be used to inform national
and global efforts to alter diet, reduce disease, and improve population health
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Tables
Table 1| Data availability and covariates used for imputation of global intakes of key dietary fats and oils
Covariates for imputation, each
year 1990-2010†
No of
household
level surveys
No of surveys
with individual
level data (NoNo of
countries (% of
global adult
population)
No of
surveysYears coveredRegions covered*
Dietary risk
factor
with age- and
sex-specific
estimates)
Survey-specific: representativeness
(nationally representative v
subnational). Country-specific: FAO
saturated fats (natural log of
percentage of total calories consumed
per capita per day in the form of
saturated fats).
075 (71)47 (70)751980-2008AE, APH, AS, ASE,
AUS, CAR, EURC,
EURE, EURW, LAC,
LAT, NA, NAM, OC,
SSS
Saturated fats
Survey-specific: metric (optimal v
secondary metric), representativeness
(nationally representative v
subnational). Country-specific: FAO
polyunsaturated fats (natural log of
percentage of total calories from
051 (51)32 (47)511986-2008AE, APH, ASE, AUS,
CAR, EURC, EURE,
EURW, LAC, LAT,
NA, NAM, SSS
Omega 6
polyunsaturated
fats
polyunsaturated fats derived from
cottonseed oil, rape/mustard seed oil,
soybean oil, sesame seed oil,
sunflower seed oil, maize germ oil,
and groundnut oil consumed per
capita per day), FAO factor variables
1-4.
Country-specific: hydrogenated oil net
ratio (ratio of hydrogenated oil to total
oil crops export), total oil/fats per
capita (log transformed total oils/fats
per capita [from retail/food service
database], in tonnes), total packaged
1046 (20)23 (19)561980-2009APH, AS, CAR,
EURW, LAC, LAT,
NA, NAM, SSS
Trans fats
foods per capita (log transformed total
packaged foods per capita [from
retail/food service database], in
tonnes).
Survey-specific: representativeness
(nationally representative v
subnational). Country-specific: FAO
animal fats (natural log of percentage
of total calories consumed per capita
per day in the form of animal fats),
070 (65)45 (53)701980-2008AE, APH, AS, ASE,
AUS, CAR, EURC,
EURE, EURW, LAC,
LAS, LAT, NA, NAM,
OC, SSS
Dietary
cholesterol
FAO eggs (natural log of percentage
of total calories consumed per capita
per day in the form of eggs).
Survey-specific: metric (optimal v
secondary metric), representativeness
(nationally representative v
subnational), diet assessment method
(diet recalls/ records or FFQ v
household availability/budget survey).
5455 (47)57 (59)1091980-2008AE, APH, AS, ASE,
AUS, CAR, EURC,
EURE, EURW, LAC,
LAT, NA, NAM, SSE,
SSS, SSW
Seafood omega
3 fats
Country-specific: FAO omega 3
polyunsaturated fats (natural log of
percentage of total calories consumed
per capita per day in the form of
omega 3 polyunsaturated fats).
Survey-specific: representativeness
(nationally representative v
subnational). Country-specific: omega
6 polyunsaturated fats (natural log of
percentage of total calories consumed
per capita per day in the form of
028 (28)21 (44)281990-2007AE, APH, CAR,
EURC, EURW, LAC,
LAT, NA, NAM, SSS
Plant omega 3
fats
omega 6 polyunsaturated fats),
soybean (natural log of percentage of
total calories consumed per capita per
day in the form of soybean and oil
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Table 1 (continued)
Covariates for imputation, each
year 1990-2010†
No of
household
level surveys
No of surveys
with individual
level data (No
with age- and
sex-specific
estimates)
No of
countries (% of
global adult
population)
No of
surveysYears coveredRegions covered*
Dietary risk
factor
from soy), hydrogenated oil net ratio
(ratio of hydrogenated oil to total oil
crops export).
FAO=United Nations Food and Agriculture Organization. FFQ=food frequency questionnaire
*Based on 21 Global Burden of Diseases, Injuries, and Risk Factors (GBD) study regions including APH=Asia Pacific, High Income; AC=Asia, Central; AE=Asia,
East, AS=Asia, South; ASE=Asia, South East; AUS=Australasia; CAR=Caribbean, EURC=Europe, Central; EURE=Europe, Eastern; EURW=Europe, Western;
LAA=Latin America, Andean; LAC=Latin America, Central; LAS=Latin America, Southern; LAT=Latin America, Tropical; NAM=North Africa/Middle East; NA=North
America, High Income; OC=Oceania; SSC=Sub-Saharan Africa, Central; SSE=Sub-Saharan Africa, East; SSS=Sub-Saharan Africa, Southern; SSW=Sub-Saharan
Africa, West.
†Year and country-specific covariates were based on the FAO annual Food Balance Sheets.16 A space-time smoothing procedure was used to generate a full time
series of consumption estimates. Income and education were used as covariates in the space-time model to improve predictions in instances of missing data. For
education, the age standardised mean number of years of education for ages ≥25 by sex as a continuous variable was used.36 For income, the estimated and
normalised lag-distributed income based on the international dollar as a continuous variable was used.35 For countries that had split or merged during the time
series (1990-2010), we split/merged these countries into constituent countries using a growth rate method to generate as close to a full time series as possible for
all countries. The FAO covariates were used in the percentage natural logarithm form (that is, the % of total energy that is comprised of a particular food). For
trans fats, the hydrogenated oil net ratio corresponded to the net amount of hydrogenated oils available for consumption in each country-year. Using the FAO
data, the numerator for this ratio (that is, hydrogenated oil exports) was calculated based on exported hydrogenated oil (in kcal per capita) and exported oil crops
(in kcal per capita) through space-time with lag-distributed income as a covariate. The denominator (that is, total oil crops, in kcal per capita) was calculated by
adding import values to production values minus the export values, and then application of space-time model provided us the complete time series covariate.
Afterward, the complete time series ratio covariate was applied to the amount of oil crops (in kcal per capita) in each country. Additional country-level time-varying
(year-specific) FAO covariates used were the four factors derived from principal component analysis of 17 standardised FAO nutrients or food groups: factor 1
included red meats, animal fats, and pig meats; factor 2 included omega 3 polyunsaturated fats, omega 6 polyunsaturated fats, whole grains, nuts, and vegetables;
factor 3 included fruits, legumes, and nuts; and factor 4 included sugars, stimulants, and saturated fats. For model fits see eFig 7 in data supplements.
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Table 2| Optimal consumption levels of key dietary fats and oils and relevant data sources*
Mean (SD) optimal
consumption**Dietary guidelines¶
Observed national mean
consumption levels (top or
bottom 3 countries)§
Observed consumption
levels associated with
lowest disease risk in
human studies‡¶
Related disease
outcomesDietary fats†
12 (1.2)%E††<10%E for saturated fats,
replacing them with
monounsaturated and
polyunsaturated fats
Top 3 countries,
polyunsaturated fats:
Turkey: 18.7%E
Bulgaria: 12.7%E
Lebanon: 9.4%E
Bottom 3 countries, saturated
fats:
Bangladesh: 2.3%E
Bahrain: 2.4%E
India: 5.1%E
Polyunsaturated fats:
14.2%E (CHD events)8 12
7.9%E (CHD deaths)8 12
Saturated fats:
4.1%E8 12
Decreased CHDPolyunsaturated fats
replacing saturated fats
250 (25) mg/day250 mg/dayTop 3 countries:
Iceland: 1189.1 mg/day
Barbados: 1178.5 mg/day
Japan: 994.6 mg/day
250 mg/day10Decreased CHDSeafood omega 3 fatty
acids
0.5 (0.05)%EAs low as possibleBottom 3 countries:
Barbados: 0.2%E
Finland: 0.4%E
Italy: 0.5%E
0%E38Increased CHDTrans fats
CHD=coronary heart disease. %E=percentage of total energy intake. SD=standard deviation
*For each dietary factor, the optimal consumption level was identified based both on observed levels at which lowest disease risk occurs and observed mean
consumption levels in at least two or three countries around the world. We also considered whether such identified levels were consistent with major dietary
guidelines.7 39
†Dietary fats for which we identified probable or convincing evidence for aetiologic effects on chronic diseases including coronary heart disease, stroke, type 2
diabetes, or cancers.19 Based on available evidence, we identified evidence for aetiologic effects on coronary heart disease of polyunsaturated fatty acids as a
replacement for saturated fats; seafood omega 3 fats; and trans fats.8 10 12 38 We did not identify convincing or probable evidence for aetiological effects of these
fats on stroke, diabetes, or cancers; or of total fat, monounsaturated fat, plant omega 3 fats, or dietary cholesterol (evaluated mainly through egg consumption)
on coronary heart disease, stroke, type 2 diabetes, or cancers.8 21 24-31
‡Observed median consumption levels in population subgroups (top or bottom quartile or quintile) associated with lowest disease risk in meta-analyses of prospective
cohort studies or randomised controlled trials.
§Observed mean national consumption levels in the top (for protective factors) or bottom (for harmful factors) three countries as identified in our global data sources.
Values are adjusted for total energy and standardised to 2000 kcal/day.34
¶Recommended intake levels for a 2,000 kcal/d diet based on the US Department of Agriculture and United Nations Food and Agriculture Organization guidelines.4
5 7 39
**Because not all individuals within a population can have the same exposure level, the plausible distribution (standard deviation) of optimal consumption was
calculated from the average standard deviation for all metabolic risk factors in the Global Burden of Diseases study (10% of the mean).
††Optimal consumption was based on increasing polyunsaturated fat to 12% energy as a replacement for saturated fat, based on the evidence that this specific
nutrient replacement reduces risk.8 12
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Table 3| Characteristics of adult global consumption of key dietary fats and oils in 2010
Plant omega 3 fats
(mg/day)
Seafood omega 3
fats (mg/day)
Dietary cholesterol
(mg/day)Trans fats (%E)
Omega 6
polyunsaturated fats
(%E)Saturated fats (%E)
Characteristics of
global
consumption
1371 (1299 to 1465)163 (154 to 172)228 (222 to 234)1.4 (1.36 to 1.44)5.9 (5.7 to 6.1)9.4 (9.2 to 9.5)Global mean
consumption (95%
UI)
302 to 3205 (10.6-fold)13 to 710 (55-fold)139 to 328 (2.4-fold)0.6 to 2.9 (4.8-fold)2.5 to 8.5 (3.4-fold)4.3 to 23.5 (5.5-fold)Range across 21
global regions
(overall variation)
East Asia (3205),
Tropical (1742) and
Southern (1288) Latin
America, High-Income
North America (1584),
Caribbean (1331)
Southeast Asia (710),
High-Income Asia
Pacific (701),Western
Europe (351),
Oceania (315),
Australasia (300)
Eastern Europe (328),
High-Income Asia
Pacific (326), Central
Europe (326),
High-Income North
America (294),
High-Income North
America (2.9), Central
(2.4), Tropical (1.8)
and Andean Latin
America (1.7), North
Africa/Middle East
(2.4)
East Asia (8.5), Eastern
(8.0) and Central (7.9)
Europe, Tropical Latin
America (6.9), Central
Asia (6.5), High-Income
North America (6.5)
Oceania (23.5),
South East Asia
(17.7), Central
Europe (14.4),
Australasia (13.6),
Eastern Europe
(13.0%)
Regions with highest
levels (mean
consumption)
Tropical Latin America
(291)
Southeast Asia (302),
East Sub-Saharan
Africa (394), Oceania
(399), South Asia (514),
Central Latin America
(552)
Southern (13) and
East (52)
Sub-Saharan Africa,
South (30), East (37),
and Central (40) Asia
South Asia (139),
Central (196), East
(202), and West (205)
Sub-Saharan Africa,
Oceania (215)
Caribbean (0.6), East
(0.8), Central (0.8),
and West (0.9)
Sub-Saharan Africa,
Central (0.9) and
Southeast (0.9) Asia,
Oceania (1.0)
Oceania (2.5),
Southeast Asia (3.2),
East (3.9), West (4.2),
and Central (4.7)
Sub-Saharan Africa,
High-Income Asia
Pacific (4.4)
South Asia (4.3),
Andean Latin
America (7.0),
Caribbean (7.4), East
Asia (7.4), Central
Latin America (7.8)
Regions with lowest
levels (mean
consumption)
South Asia†,
Australasia†, Southern†
Latin America,
Oceania†, Eastern
Europe†
Latin America†,
Oceania†
South Asia‡, Eastern
Europe*, Oceania*,
Central† and West†
Sub-Saharan Africa,
Andean Latin
America†
Oceania†‡, East†‡,
Central†‡ and
Southern†‡
Sub-Saharan Africa
South Asia†, Eastern
Europe†, Southern†
and Andean† Latin
America, Oceania†,
Central† and West†
Sub-Saharan Africa,
Caribbean†
Oceania*, Eastern
Europe*, Central†
and West†
Sub-Saharan Africa,
Andean† and
Southern† Latin
America
Regions with greater
statistical uncertainty
2 to 5542 (2731-fold)5 to 3886 (840-fold)97 to 440 (4.5-fold)0.2 to 6.5 (28.1-fold)1.2 to 12.5 (10.5-fold)2.3 to 27.5 (12.2-fold)Range across 187
countries (overall
variation)
Jamaica (5542), China
(3266), UK (2414),
Tunisia (2215), Angola
(2195), Canada (2085),
Brazil (1747), Paraguay
(1575), US (1527),
Maldives (3886),
Barbados (1986),
Seychelles (1291),
Iceland (1229),
Denmark (1225),
Malaysia (988),
Romania (439), Algeria
(402), Latvia (367),
Belarus (352),
Lithuania (348mg/day),
Denmark (348),
Paraguay (347), Japan
(347), Hungary (337)
Egypt (6.5), Pakistan
(5.8), Canada (4.0),
Mexico (3.6), Bahrain
(3.2)
Bulgaria (12.5), other
Central European
nations (8.9 to 9.9),
Lebanon (9.9),
Kazakhstan (8.9),
Belarus (8.5)
Samoa (27.5), Kiribati
(27.0), similar palm
oil producing island
nations (22.8 to
25.7), Sri Lanka
(21.9), Romania
(21.4), Malaysia
(20.3)
Countries with
highest levels (mean
consumption)
Uruguay (1384),
Argentina (1304)
Thailand (824), Japan
(718), South Korea
(708)
Israel (2), Solomon
Islands (102), Sri Lanka
(106), Comoros (126),
Saint Lucia (129),
Philippines (131)
Zimbabwe (5),
Lebanon (8),
Occupied Palestinian
Territory (8),
Botswana (10),
Guinea-Bissau (10)
Bangladesh (97),
Nepal (116), other
South Asian nations
(121 to 157), Rwanda
(155), Burundi (163),
Tajikistan (169),
Ghana (169)
Barbados (0.2), Haiti
(0.4), other island
nations in the
Caribbean (0.5 to0.6),
Ethiopia (0.6), Eritrea
(0.6), other East
Sub-Saharan African
nations (0.6 to 0.7)
Kiribati (1.2), Samoa
(1.5), Vanuatu (1.5),
Maldives (1.6), Sri
Lanka (1.6), Solomon
Islands (1.7)
Bangladesh (2.3),
Nepal (2.7), Bolivia
(3.2), Bhutan (3.2),
Pakistan (3.8)
Countries with
lowest levels (mean
consumption)
1120 (1006 to 1270)351 (314 to 393)290 (279 to 302)1.1 (1.1 to 1.2)5.2 (4.9 to 5.5)12.6 (12.3 to 13.9)Western Europe
mean consumption
(95% UI)
2 in Israel and 300 in
Denmark to 2014 in
Finland and 2414 in the
UK
97 in Ireland and 180
in Netherlands to
1225 in Denmark and
1229 in Iceland
215 in Greece and 222
in Luxemburg to 333 in
Austria and 348 in
Denmark
0.8 in Finland, Italy,
and Malta to 1.6 in
Switzerland and 2.3 in
the Netherlands
2.7 in Denmark and 2.9
in Iceland to 6.4 in
Spain and 8.0 in Israel
8.2 in Luxemburg and
9.0 in Malta to 14.7 in
Belgium and 14.8 in
Austria
Western Europe
range with country
examples
1527 (1456 to 1599)141 (128 to 157)296 (284 to 306)2.8 (2.5 to 3.1)6.7 (6.5 to 7.0)11.8 (11.5 to 12.2)US mean
consumption (95%
UI)
≥0.5%E, or ≥1100 mg
for a 2000 kcal/day
diet**: 52 countries,
1.94bn people (43.9%)
≥250 mg/day: 45
countries, 837.2m
people (18.9%)
<300 mg/day¶: 155
countries, 3.9bn
people (87.6%)
≤0.5%E: 12 countries,
24.43m people (0.6%)
≥12%E§; 1 country,
6.1m people (0.1%)
≥5%E: 94 countries,
2.32bn people (52.4%)
<10%E§: 75
countries, 2.73bn
people (61.8%)
No of countries
achieving optimal
mean intakes,
corresponding adult
population (% of
global total)
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Table 3 (continued)
Plant omega 3 fats
(mg/day)
Seafood omega 3
fats (mg/day)
Dietary cholesterol
(mg/day)Trans fats (%E)
Omega 6
polyunsaturated fats
(%E)Saturated fats (%E)
Characteristics of
global
consumption
<0.5%E, or <1100 mg
for a 2000 kcal/day diet:
<250 mg/day: 142
countries, 3.58bn
people (81.1%)
<100 mg/day: 100
countries, 2.95bn
people (66.8%)
≥300 mg/day: 32
countries, 547.9m
people (12.4%)
>0.5%E: 175
countries, 4.42bn
people (99.4%)
>2.0%E: 12 countries,
643.7m people
(14.6%)
<12%E: 186 countries,
4.42bn people (99.9%)
<5%E: 93 countries,
2.1bn people (47.6%)
≥10%E: 112
countries, 1.69bn
people (38.2%)
No of countries not
achieving optimal
mean intakes,
corresponding adult
population (% of
global total)
135 countries, 2.48bn
people (56.1%)
<500 mg/day: 61
countries, 788.7m
people (17.8%)
UI=uncertainty interval. %E=percentage of total energy intake. bn=billion. m=million.
*Due to higher within-country statistical uncertainty in the raw data.
†Due to limited country-specific raw data on consumption levels.
‡Due to greater variation in consumption levels between countries in the region.
§Based on optimal consumption levels for polyunsaturated fats as a replacement for saturated fats.
¶We did not identify sufficient evidence to set a specific optimal intake level for preventing chronic diseases. The value here is based on recommended consumption
levels in the 2010 Dietary Guidelines for Americans.7
**We did not identify sufficient evidence to set a specific optimal intake level for preventing chronic diseases. The value here is based onWorld Health Organization
guidelines for adequate intakes.6
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Figures
Fig 1 Flow diagram of systematic search for nationally representative surveys of food and nutrient intake
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Fig 2 Global and regional mean consumption levels of dietary saturated fat and omega 6 polyunsaturated fat in 2010 for
adults aged ≥20 years. See eTable 3 of data supplement for numerical mean estimates and uncertainty intervals
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Fig 3 Global and regional mean consumption levels of dietary trans fat and cholesterol in 2010 for adults ≥20 years of age.
See eTable 3 of data supplement for numerical mean estimates and uncertainty intervals
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Fig 4Global and regional mean consumption levels of dietary seafood omega 3 fat and plant omega 3 fat in 2010 for adults
≥20 years of age. See eTable 3 of data supplement for numerical mean estimates and uncertainty intervals
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Fig 5 Global and regional mean consumption levels in 1990 and 2010 of dietary saturated fat, omega 6 polyunsaturated
fat, trans fat, cholesterol, seafood omega 3 fat, and plant omega 3 fat for adults ≥20 years of age in relation to their uncertainty.
See eTables 3 and 4 of data supplement for numerical mean estimates and uncertainty intervals
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